Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: A 20‐year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT)

Documenti analoghi

• The Role of Chimeric Antigen Receptor T‐Cell Therapy in Immune‐Mediated Neurological Diseases
  di: Gavin Brittain, et al.
  Pubblicazione: (2024)
• UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT ): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies ( BSBMTCT ), NHS England Genomic Laboratory Hub ( GLH ) Haematological Malignancies Working Group, UK Cancer Genetics Group ( UKCGG ) and the UK National External Quality Assessment Service for Leucocyte Immunophenotyping ( UK NEQAS LI )
  di: Andrew Clark, et al.
  Pubblicazione: (2025)
• Position statement from the British Society of Blood and Marrow Transplantation and Cellular Therapy on insertional oncogenesis in gene‐engineered advanced cell therapy products for treatment of haematological disorders
  di: S. Ghorashian, et al.
  Pubblicazione: (2025)
• Effects of therapeutic ultrasound on haematological dynamics and fibrinogen during the inflammatory phase after muscle injury in rats
  di: Luis Ulisses Signori
  Pubblicazione: (2014)
• Relapse‐Associated and Relapse‐Independent Contribution to Overall Expanded Disability Status Scale Progression in Multiple Sclerosis Patients Diagnosed in Different Eras
  di: Noemi Montobbio, et al.
  Pubblicazione: (2024)